Issued Patents 2025
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12404314 | Switch costimulatory receptors | Yangbing Zhao | 2025-09-02 |
| 12350334 | Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer | Matthew J. Frigault, Yangbing Zhao, John Scholler | 2025-07-08 |
| 12344657 | CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell | Hans Bitter, Jennifer Bordeaux, Barbara Brannetti, Jennifer Brogdon, Naveen Dakappagari +12 more | 2025-07-01 |
| 12344843 | Altering gene expression in cart cells and uses thereof | Yangbing Zhao, Jiangtao Ren, Xiaojun Liu | 2025-07-01 |
| 12325756 | Use of trans-signaling approach in chimeric antigen receptors | Daniel J. Powell, Jr. | 2025-06-10 |
| 12240884 | Methods for improving the efficacy and expansion of immune cells | Felipe Bedoya, Saba Ghassemi, Omkar U. Kawalekar, Bruce L. Levine, Jan J. Melenhorst +3 more | 2025-03-04 |
| 12234274 | Use of the CD2 signaling domain in second-generation chimeric antigen receptors | John Scholler, Avery D. Posey | 2025-02-25 |
| 12227588 | Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias | Marco Ruella, Saar Gill, Avery D. Posey, Daniel J. Powell, Jr. | 2025-02-18 |
| 12215137 | Compositions and methods for T cell delivery of therapeutic molecules | Yangbing Zhao, Xiaojun Liu | 2025-02-04 |
| 12214037 | Treatment of cancer using humanized anti-BCMA chimeric antigen receptor | Jennifer Brogdon, Eugene Choi, Hilmar Erhard Ebersbach, David Glass, Heather Huet +9 more | 2025-02-04 |